{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:08:07Z","timestamp":1790212087746,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017501","name":"Science Health Joint Medical Scientific Research Project of Chongqing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jconrel.2026.115206","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:03:25Z","timestamp":1784934205000},"page":"115206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tumor-targeted CD40 ligand-functionalized extracellular vesicle mimetics enable chemoimmunotherapy for neuroblastoma"],"prefix":"10.1016","volume":"398","author":[{"given":"Jinkui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.jconrel.2026.115206_bb0005","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1200\/JCO.2014.59.4648","article-title":"Advances in risk classification and treatment strategies for neuroblastoma","volume":"33","author":"Pinto","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.115206_bb0010","first-page":"1","article-title":"High-risk and relapsed neuroblastoma: toward more cures and better outcomes","volume":"42","author":"DuBois","year":"2022","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"10","key":"10.1016\/j.jconrel.2026.115206_bb0015","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.3390\/cancers16101863","article-title":"The neuroblastoma microenvironment, heterogeneity and immunotherapeutic approaches","volume":"16","author":"Polychronopoulos","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2026.115206_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2013.00167","article-title":"Immunosuppressive microenvironment in neuroblastoma","volume":"3","author":"Pistoia","year":"2013","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115206_bb0025","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004807","article-title":"Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma","volume":"10","author":"Costa","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"15","key":"10.1016\/j.jconrel.2026.115206_bb0030","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1158\/0008-5472.CAN-14-3443","article-title":"Neuroblastoma arginase activity creates an immunosuppressive microenvironment that impairs autologous and engineered immunity","volume":"75","author":"Mussai","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.115206_bb0035","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3389\/fimmu.2020.01947","article-title":"\u201cRe-educating\u201d tumor associated macrophages as a novel immunotherapy strategy for neuroblastoma","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115206_bb0040","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3390\/cells12060885","article-title":"Monocyte and macrophage in neuroblastoma: blocking their pro-tumoral functions and strengthening their crosstalk with natural killer cells","volume":"12","author":"Vitale","year":"2023","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115206_bb0045","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3390\/pharmaceutics12121146","article-title":"Extracellular vesicles as drug delivery systems in cancer","volume":"12","author":"Hernandez-Oller","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115206_bb0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12575-023-00220-3","article-title":"Extracellular vesicles for drug delivery in cancer treatment","volume":"25","author":"Wang","year":"2023","journal-title":"Biol. Proced. Online"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115206_bb0055","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2174\/1567201820666230712103942","article-title":"Engineered exosomes for drug delivery in cancer therapy: a promising approach and application","volume":"21","author":"Fu","year":"2024","journal-title":"Curr. Drug Deliv."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115206_bb0060","doi-asserted-by":"crossref","first-page":"165","DOI":"10.20517\/evcna.2025.161","article-title":"80 years of extracellular vesicles: from discovery to clinical translation","volume":"7","author":"Li","year":"2026","journal-title":"Extracell Vesicles Circ. Nucl. Acids"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115206_bb0065","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.fmre.2024.03.025","article-title":"Engineering exosomes and exosome-like nanovesicles for improving tissue targeting and retention","volume":"5","author":"Li","year":"2024","journal-title":"Fundam. Res."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115206_bb0070","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1021\/nn402232g","article-title":"Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors","volume":"7","author":"Jang","year":"2013","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115206_bb0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/14737140.2017.1270208","article-title":"Cancer immunotherapy: activating innate and adaptive immunity through CD40 agonists","volume":"17","author":"Beatty","year":"2017","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.jconrel.2026.115206_bb0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cytogfr.2023.11.002","article-title":"Harnessing the potential of CD40 agonism in cancer therapy","volume":"75","author":"Zhou","year":"2024","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jconrel.2026.115206_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113658","article-title":"Engineered vesicular cancer vaccines for immunosuppressive microenvironment reversion and in situ vaccine generation","volume":"382","author":"Li","year":"2025","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115206_bb0090","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0014-5793(94)01108-7","article-title":"Functional expression of nicotinic acetylcholine receptors containing rat alpha 7 subunits in human SH-SY5Y neuroblastoma cells","volume":"354","author":"Puchacz","year":"1994","journal-title":"FEBS Lett."},{"issue":"40","key":"10.1016\/j.jconrel.2026.115206_bb0095","doi-asserted-by":"crossref","first-page":"53555","DOI":"10.1021\/acsami.4c11979","article-title":"Targeted gold nanoclusters for synergistic high-risk neuroblastoma therapy through noncanonical ferroptosis","volume":"16","author":"Xue","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.115206_bb0100","article-title":"The neuroblastoma tumor microenvironment: from an in-depth characterization towards novel therapies","volume":"3","author":"Louault","year":"2024","journal-title":"EJC Paediatr. Oncol."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115206_bb0105","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.it.2019.02.003","article-title":"Targeting tumor-associated macrophages in cancer","volume":"40","author":"Pathria","year":"2019","journal-title":"Trends Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115206_bb0110","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/cells9010046","article-title":"Current strategies to target tumor-associated-macrophages to improve anti-tumor immune responses","volume":"9","author":"Anfray","year":"2020","journal-title":"Cells"},{"issue":"17","key":"10.1016\/j.jconrel.2026.115206_bb0115","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.2217\/nnm-2020-0071","article-title":"Development of CD40L-modified tumor small extracellular vesicles for effective induction of antitumor immune response","volume":"15","author":"Liu","year":"2020","journal-title":"Nanomedicine (London)"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115206_bb0120","article-title":"Understanding the influence of the tumor microenvironment on macrophage responses to CD40 agonists","volume":"3","author":"Luheshi","year":"2014","journal-title":"Oncoimmunology"},{"issue":"18","key":"10.1016\/j.jconrel.2026.115206_bb0125","first-page":"3505","article-title":"Efficacy of CD40 agonists is mediated by distinct cDC subsets and subverted by suppressive macrophages","volume":"82","author":"Murgaski","year":"2022","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115206_bb0130","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.20050915","article-title":"Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death","volume":"202","author":"Casares","year":"2005","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115206_bb0135","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm1523","article-title":"Calreticulin exposure dictates the immunogenicity of cancer cell death","volume":"13","author":"Obeid","year":"2007","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115206_bb0140","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2026.115206_bb0145","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jconrel.2020.03.039","article-title":"Extracellular vesicles for tumor targeting delivery based on five features principle","volume":"322","author":"Yong","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115206_bb0150","article-title":"Extracellular vesicle\/macrophage axis: potential targets for inflammatory disease intervention","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115206_bb0155","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.actbio.2021.09.003","article-title":"Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis","volume":"135","author":"Hu","year":"2021","journal-title":"Acta Biomater."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115206_bb0160","doi-asserted-by":"crossref","first-page":"6863","DOI":"10.1021\/acsnano.3c06987","article-title":"Engineered bacterial biomimetic vesicles reprogram tumor-associated macrophages and remodel tumor microenvironment to promote innate and adaptive antitumor immune responses","volume":"18","author":"Zheng","year":"2024","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115206_bb0165","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001408","article-title":"Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control: a review","volume":"8","author":"Lecoultre","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2026.115206_bb0170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2024.08.008","article-title":"Engineered bacterial membrane vesicle as safe and efficient nano-heaters to reprogram tumor microenvironment for enhanced immunotherapy","volume":"374","author":"Liu","year":"2024","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926006103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926006103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:54:59Z","timestamp":1790211299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926006103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":34,"alternative-id":["S0168365926006103"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115206","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-targeted CD40 ligand-functionalized extracellular vesicle mimetics enable chemoimmunotherapy for neuroblastoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115206"}}